Your browser is no longer supported. Please, upgrade your browser.
OCX OncoCyte Corporation daily Stock Chart
OncoCyte Corporation
Index- P/E- EPS (ttm)-0.38 Insider Own47.30% Shs Outstand48.44M Perf Week22.57%
Market Cap249.95M Forward P/E- EPS next Y-0.38 Insider Trans- Shs Float27.39M Perf Month24.34%
Income-15.80M PEG- EPS next Q-0.09 Inst Own31.10% Short Float3.02% Perf Quarter35.43%
Sales- P/S- EPS this Y35.10% Inst Trans106.94% Short Ratio2.70 Perf Half Y203.53%
Book/sh0.82 P/B6.29 EPS next Y-8.10% ROA-83.00% Target Price7.15 Perf Year106.40%
Cash/sh0.82 P/C6.26 EPS next 5Y- ROE-113.20% 52W Range1.16 - 6.92 Perf YTD273.91%
Dividend- P/FCF- EPS past 5Y10.80% ROI- 52W High-25.43% Beta6.24
Dividend %- Quick Ratio12.80 Sales past 5Y- Gross Margin- 52W Low342.92% ATR0.37
Employees12 Current Ratio12.80 Sales Q/Q- Oper. Margin- RSI (14)64.39 Volatility13.22% 7.85%
OptionableYes Debt/Eq0.04 EPS Q/Q30.60% Profit Margin- Rel Volume1.21 Prev Close5.45
ShortableYes LT Debt/Eq0.01 EarningsMay 14 AMC Payout- Avg Volume306.33K Price5.16
Recom1.80 SMA2016.05% SMA5024.84% SMA20084.55% Volume372,148 Change-5.32%
Feb-13-19Initiated Piper Jaffray Overweight $6
Jan-29-19Upgrade Janney Neutral → Buy
Dec-19-18Resumed Lake Street Buy
May-20-19 10:20AM  OncoCyte (OCX) Catches Eye: Stock Jumps 7.3% Zacks -5.32%
May-14-19 11:44PM  OncoCyte Corporation (OCX) Q1 2019 Earnings Call Transcript Motley Fool
04:18PM  OncoCyte: 1Q Earnings Snapshot Associated Press
04:05PM  OncoCyte Provides Corporate Update and Reports First Quarter 2019 Financial Results GlobeNewswire
02:30PM  OncoCyte Corp. to Host Earnings Call ACCESSWIRE
May-08-19 04:01PM  OncoCyte to Report First Quarter 2019 Financial Results on Tuesday, May 14 GlobeNewswire
Apr-25-19 08:00AM  OncoCyte Announces Successful Completion of Analytical Validation Study and Commencement of CLIA Validation Study GlobeNewswire
Apr-24-19 12:06PM  The OncoCyte (NYSEMKT:OCX) Share Price Has Gained 106%, So Why Not Pay It Some Attention? Simply Wall St.
Apr-01-19 04:20PM  OncoCyte: 4Q Earnings Snapshot Associated Press +7.59%
04:06PM  OncoCyte Provides Corporate Update and Reports Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
04:05PM  OncoCyte to Present Late Breaking Abstract at the American Thoracic Society 2019 International Conference GlobeNewswire
02:30PM  OncoCyte Corp. to Host Earnings Call ACCESSWIRE
Mar-25-19 04:05PM  OncoCyte to Report Fourth Quarter and Full-Year 2018 Financial Results on Monday, April 1, 2019 GlobeNewswire
Mar-20-19 11:05AM  Teladoc to Acquire MedecinDirect, Expand Overseas Business Zacks
Mar-06-19 04:15PM  OncoCyte Corporation to Present at Cowen and Company 39th Annual Health Care Conference in Boston GlobeNewswire
Mar-04-19 04:05PM  OncoCyte Announces Initiation of Analytical Validation Study GlobeNewswire
Feb-14-19 08:00AM  BioTime Provides Business Update Including Information on AgeX, OncoCyte and Asterias GlobeNewswire
Feb-12-19 04:05PM  OncoCyte Announces Closing of Public Offering of Common Stock GlobeNewswire
Feb-08-19 09:00AM  OncoCyte Announces Pricing of Public Offering of Common Stock GlobeNewswire -6.98%
Feb-07-19 04:05PM  OncoCyte Announces Proposed Public Offering of Common Stock GlobeNewswire
Jan-31-19 11:05AM  OncoCyte soars after promising results from its cancer detection tests Yahoo Finance Video -9.42%
Jan-30-19 12:15PM  Here's Why OncoCyte Is Giving Back Some Gains Today Motley Fool -12.01%
08:30AM  Has OncoCyte Changed How We Will Diagnose Cancer in the Near Future? ACCESSWIRE
08:00AM  Today's Research Reports on Trending Tickers: Amgen and OncoCyte ACCESSWIRE
Jan-29-19 02:30PM  These 4 Healthcare Stocks Healthy With Potential Opportunities ACCESSWIRE +224.73%
02:14PM  OncoCyte upgraded to buy at Janney on high hopes for lung cancer biopsy test MarketWatch
10:25AM  Tiny Health Stock Triples After Lung Cancer Test Wins Wall Street Praise Bloomberg
08:47AM  OncoCyte's stock doubles on heavy volume after positive results of cancer detection test MarketWatch
07:14AM  OncoCyte Announces Successful Results of DetermaVu R&D Validation Study GlobeNewswire
Jan-28-19 04:30PM  OncoCyte Schedules Announcement and Conference Call to Discuss Results from Key R&D Validation Study of DetermaVu GlobeNewswire -5.21%
Jan-03-19 08:00AM  OncoCyte Announces Transition to Ion Torrent Next-Generation Sequencing Platform GlobeNewswire +5.44%
Dec-20-18 04:18PM  OncoCyte Provides Progress Update on Ongoing Studies GlobeNewswire
Nov-30-18 10:38AM  OncoCyte Corporation to Present at the LD Micro 11th Annual Main Event Investor Conference GlobeNewswire
Nov-26-18 07:50AM  Report: Developing Opportunities within Summit Midstream Partners, LP, Empire State Realty Trust, Expeditors International of Washington, Ellington Residential Mortgage REIT, OncoCyte, and Sachem Capital Future Expectations, Projections Moving into 2018 GlobeNewswire -7.78%
Nov-19-18 04:05PM  OncoCyte Corporation to Present at the Piper Jaffray 30th Annual Health Care Conference GlobeNewswire
Nov-13-18 06:08PM  OncoCyte: 3Q Earnings Snapshot Associated Press
04:05PM  OncoCyte Reports Third Quarter 2018 Financial Results and Progress in DetermaVu Development GlobeNewswire
Nov-06-18 09:00AM  Oncocyte to Report Third Quarter 2018 Financial Results on November 13, 2018 GlobeNewswire
Oct-29-18 04:05PM  OncoCyte Completes Successful Transition to New Diagnostic Testing Platform and Initiates DetermaVu Development Studies GlobeNewswire
Oct-17-18 08:00AM  OncoCyte Corporation to Present at the BIO CEO Investor Forum GlobeNewswire
Aug-14-18 05:50PM  OncoCyte: 2Q Earnings Snapshot Associated Press +9.62%
04:10PM  OncoCyte Reports Second Quarter 2018 Financial Results and Positive Corporate Developments GlobeNewswire
Aug-13-18 02:43PM  Who Are The Major Shareholders In OncoCyte Corporation (NYSEMKT:OCX)? Simply Wall St.
Aug-09-18 04:10PM  Seasoned Healthcare Executive Albert P. Parker Appointed Chief Operating Officer of OncoCyte GlobeNewswire
Jul-30-18 07:00AM  OncoCyte to Report Second Quarter 2018 Financial Results on August 14, 2018 GlobeNewswire
Jul-27-18 09:00AM  OncoCyte Announces At-Market $3.59 Million Offering of Common Stock and Warrants GlobeNewswire -5.26%
Jul-11-18 08:36AM  OncoCyte (OCX) in Focus: Stock Moves 13.1% Higher Zacks -8.70%
08:10AM  Today's Research Reports on Stocks to Watch: Loxo Oncology and OnoCyte ACCESSWIRE
Jul-10-18 05:46PM  OncoCyte (OCX) Stock Skyrockets on Lung Cancer Test Study Results InvestorPlace +13.11%
09:34AM  OncoCyte Surges on 'Encouraging' Results for Diagnostic Test for Cancer
08:11AM  Benzinga's Daily Biotech Pulse: Acceleron On Fast Lane, OncoCyte's Accurate Diagnosis, Inspire Medical Gets Aetna Coverage Benzinga
Jul-09-18 04:10PM  OncoCyte Reports Encouraging New Study Results for Lung Cancer Blood Test GlobeNewswire
Jul-02-18 05:02AM  OncoCyte Sees Hammer Chart Pattern: Time to Buy? Zacks
Jun-13-18 07:53AM  Envision Healthcare to Go Private With Acquisition by KKR Zacks
Jun-05-18 07:48AM  Teladoc (TDOC) Buys Advance Medical to Boost Global Presence Zacks +15.09%
May-31-18 06:40AM  Can The Uptrend Continue for OncoCyte (OCX)? Zacks +14.04%
May-16-18 02:49PM  Investing Focused in Canada, U.S. and Europe, Says Onex CEO Bloomberg Video
May-15-18 05:50PM  OncoCyte: 1Q Earnings Snapshot Associated Press
04:10PM  OncoCyte Reports First Quarter 2018 Financial Results GlobeNewswire
May-08-18 07:00AM  OncoCyte to Report First Quarter 2018 Financial Results on May 15, 2018 GlobeNewswire
Apr-03-18 07:00AM  Leading Molecular Diagnostics Executive Ronnie Andrews Appointed to OncoCytes Board of Directors GlobeNewswire
Apr-02-18 05:17PM  OncoCyte reports 4Q loss Associated Press +7.14%
04:12PM  OncoCyte Reports Fourth Quarter and Full Year 2017 Financial Results GlobeNewswire
04:10PM  OncoCyte Files Patents for 190 Newly Identified Novel Lung Cancer Biomarkers GlobeNewswire
07:00AM  OncoCyte Names Cavan Redmond Chairman of the Board of Directors GlobeNewswire
Mar-30-18 08:55PM  Does OncoCyte Corporations (NYSEMKT:OCX) CEO Pay Compare Well With Peers? Simply Wall St.
Mar-29-18 07:00AM  OncoCyte to Report Fourth Quarter and Full Year 2017 Financial Results on April 2, 2018 GlobeNewswire +61.54%
Mar-28-18 08:40PM  OncoCyte Announces the Closing of a $10 Million Private Placement of Common Stock GlobeNewswire
Mar-22-18 07:38PM  What You Must Know About OncoCyte Corporations (NYSEMKT:OCX) Market Risks Simply Wall St. -13.33%
Mar-14-18 05:10PM  OncoCyte Corporation (NYSEMKT:OCX) Is Expected To Breakeven Simply Wall St. +7.50%
OncoCyte Corporation focuses on the development and commercialization of novel and non-invasive blood and urine (liquid biopsy) diagnostic tests for the early detection of cancer. The company is developing diagnostic tests using genetic and protein markers expressed in various types of cancer. It develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancer. The company was founded in 2009 and is based in Alameda, California. OncoCyte Corporation is a subsidiary of BioTime, Inc.